Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$572M |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$495M |
| 3 |
iShares MBS ETF
MBB
|
+$405M |
| 4 |
Procter & Gamble
PG
|
+$365M |
| 5 |
Microsoft
MSFT
|
+$327M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco QQQ Trust
QQQ
|
+$605M |
| 2 |
iShares Russell 2000 ETF
IWM
|
+$544M |
| 3 |
Sempra
SRE
|
+$474M |
| 4 |
CELG
Celgene Corp
CELG
|
+$411M |
| 5 |
BPL
Buckeye Partners, L.P.
BPL
|
+$380M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 8.85% |
| 2 | Healthcare | 5.77% |
| 3 | Financials | 5.26% |
| 4 | Consumer Discretionary | 4.71% |
| 5 | Communication Services | 4.69% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2926
Moelis & Co
MC
$4.94B
| $2.09M | ﹤0.01% |
65,494
-2,489
| -4% | -$81.5K |
|
|
MRC
2927
DELISTED
MRC Global
MRC
| $2.09M | ﹤0.01% |
152,996
+81,222
| +113% | +$1.06M |
|
2928
PUT
PACCAR
PCAR
$70.1B
| $2.09M | ﹤0.01% |
39,600
-16,650
| -30% | -$856K |
|
2929
James River Group Holdings
JRVR
$217M
| $2.09M | ﹤0.01% |
50,658
+17,805
| +54% | +$700K |
|
2930
Supernus Pharmaceuticals
SUPN
$2.77B
| $2.09M | ﹤0.01% |
87,935
+26,507
| +43% | +$644K |
|
|
FOE
2931
DELISTED
Ferro Corporation
FOE
| $2.08M | ﹤0.01% |
140,506
+32,238
| +30% | +$416K |
|
2932
Benchmark Electronics
BHE
$2.96B
| $2.08M | ﹤0.01% |
60,551
+14,204
| +31% | +$469K |
|
2933
Cemex
CX
$16.3B
| $2.08M | ﹤0.01% |
550,277
-128,116
| -19% | -$488K |
|
|
WLL
2934
CALL
DELISTED
Whiting Petroleum Corporation
WLL
| $2.08M | ﹤0.01% |
3,779
-508
| -12% | -$246K |
|
2935
BJ's Restaurants
BJRI
$1.48B
| $2.08M | ﹤0.01% |
54,733
+3,140
| +6% | +$120K |
|
2936
Hamilton Lane
HLNE
$5.57B
| $2.08M | ﹤0.01% |
34,841
+3,011
| +9% | +$174K |
|
2937
Heron Therapeutics
HRTX
$92.9M
| $2.07M | ﹤0.01% |
88,270
-6,184
| -7% | -$137K |
|
2938
Mueller Water Products
MWA
$4.17B
| $2.07M | ﹤0.01% |
173,009
+72,243
| +72% | +$825K |
|
|
OPLN
2939
Openlane
OPLN
$4.54B
| $2.07M | ﹤0.01% |
94,960
-149,688
| -61% | -$3.41M |
|
2940
EQT Corp
EQT
$32.3B
| $2.07M | ﹤0.01% |
189,693
-16,011
| -8% | -$157K |
|
|
PRO
2941
DELISTED
PROS Holdings
PRO
| $2.07M | ﹤0.01% |
34,490
-6,738
| -16% | -$389K |
|
|
CTLT
2942
DELISTED
CATALENT, INC.
CTLT
| $2.07M | ﹤0.01% |
36,703
-33,261
| -48% | -$1.7M |
|
2943
CALL
Plains All American Pipeline
PAA
$16.1B
| $2.06M | ﹤0.01% |
112,300
+50,900
| +83% | +$935K |
|
2944
Safety Insurance
SAFT
$1.52B
| $2.06M | ﹤0.01% |
22,326
+5,117
| +30% | +$499K |
|
|
CVET
2945
PUT
DELISTED
Covetrus, Inc. Common Stock
CVET
| $2.06M | ﹤0.01% |
+156,400
| New | +$1.89M |
|
2946
PUT
ProShares Trust UltraShort Lehman 20+ Year Treasury
TBT
$312M
| $2.06M | ﹤0.01% |
77,700
-6,900
| -8% | -$176K |
|
|
MGP
2947
DELISTED
MGM Growth Properties LLC Class A common shares representing limited liability company interests
MGP
| $2.06M | ﹤0.01% |
66,576
+45,843
| +221% | +$1.41M |
|
|
LTHM
2948
DELISTED
Livent Corporation
LTHM
| $2.06M | ﹤0.01% |
240,538
+75,774
| +46% | +$580K |
|
|
SAGE
2949
PUT
DELISTED
Sage Therapeutics
SAGE
| $2.06M | ﹤0.01% |
28,500
-12,400
| -30% | -$1.53M |
|
2950
Genesco
GCO
$422M
| $2.06M | ﹤0.01% |
42,927
-5,396
| -11% | -$224K |
|
Similar funds
Barclays's Q4 2019 Portfolio in Review
As of Q4 2019, Barclays held 7,254 positions worth $180B, up 13% from $160B the previous quarter. Its ten largest holdings account for 26% of the portfolio.
Barclays deployed $6.1B of net new capital in Q4 2019, opening 260 new positions and adding to 3,541 existing holdings. Its largest new stake was Pacer iPath Gold ETNs: 1,000,000 shares worth $25.3M.
By sector, the portfolio is most concentrated in Technology at 8.9% of assets, up from 7.7% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Invesco QQQ Trust, an estimated $605M trimmed.
- Barclays's largest Q4 2019 buy was Pacer iPath Gold ETNs: 1,000,000 shares worth $25.3M.
- Barclays added most to Apple in Q4 2019, an estimated $572M increase.
- Barclays's biggest Q4 2019 reduction was Invesco QQQ Trust, cutting an estimated $605M.
- Barclays fully exited Celgene Corp in Q4 2019, selling an estimated $411M.
- Barclays's ten largest holdings make up 26% of its $180B portfolio in Q4 2019.
- Barclays opened 260 new positions and closed 700 in Q4 2019.
- Barclays's portfolio value rose 13% quarter-over-quarter to $180B.
Based on Barclays's 13F filing for Q4 2019, filed 10 Feb 2020.